JP2014024874A5 - - Google Patents

Download PDF

Info

Publication number
JP2014024874A5
JP2014024874A5 JP2013231673A JP2013231673A JP2014024874A5 JP 2014024874 A5 JP2014024874 A5 JP 2014024874A5 JP 2013231673 A JP2013231673 A JP 2013231673A JP 2013231673 A JP2013231673 A JP 2013231673A JP 2014024874 A5 JP2014024874 A5 JP 2014024874A5
Authority
JP
Japan
Prior art keywords
tableting
dissolution
improving
composition
magnesium stearate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013231673A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014024874A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2013231673A priority Critical patent/JP2014024874A/ja
Priority claimed from JP2013231673A external-priority patent/JP2014024874A/ja
Publication of JP2014024874A publication Critical patent/JP2014024874A/ja
Publication of JP2014024874A5 publication Critical patent/JP2014024874A5/ja
Pending legal-status Critical Current

Links

JP2013231673A 2006-06-27 2013-11-08 圧縮製剤 Pending JP2014024874A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2013231673A JP2014024874A (ja) 2006-06-27 2013-11-08 圧縮製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006176146 2006-06-27
JP2006176146 2006-06-27
JP2013231673A JP2014024874A (ja) 2006-06-27 2013-11-08 圧縮製剤

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2008522575A Division JP5769362B2 (ja) 2006-06-27 2007-06-26 圧縮製剤

Publications (2)

Publication Number Publication Date
JP2014024874A JP2014024874A (ja) 2014-02-06
JP2014024874A5 true JP2014024874A5 (enExample) 2014-08-07

Family

ID=38845498

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008522575A Active JP5769362B2 (ja) 2006-06-27 2007-06-26 圧縮製剤
JP2013231673A Pending JP2014024874A (ja) 2006-06-27 2013-11-08 圧縮製剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2008522575A Active JP5769362B2 (ja) 2006-06-27 2007-06-26 圧縮製剤

Country Status (9)

Country Link
US (1) US20100237530A1 (enExample)
EP (1) EP2033643A4 (enExample)
JP (2) JP5769362B2 (enExample)
KR (1) KR101628028B1 (enExample)
CN (1) CN101478966B (enExample)
BR (1) BRPI0713371A2 (enExample)
CA (1) CA2656181C (enExample)
TW (1) TWI492747B (enExample)
WO (1) WO2008001734A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110038898A1 (en) * 2008-03-13 2011-02-17 Shuichi Yada Dissolution properties of drug products containing olmesartan medoxomil
JP2011136908A (ja) * 2009-12-25 2011-07-14 Kyowa Yakuhin Kogyo Kk アンギオテンシンii受容体拮抗剤を含む固形製剤および固形製剤におけるアンギオテンシンii受容体拮抗剤の保存安定性向上方法
CN102119930B (zh) * 2010-07-13 2013-01-30 福建天泉药业股份有限公司 一种奥美沙坦酯片及制备方法
EP2425859A1 (en) 2010-08-08 2012-03-07 Abdi Ibrahim Ilac Sanayi ve Ticaret Anonim Sirketi Olmesartan formulations
CN102028663B (zh) * 2010-12-14 2011-11-30 北京万生药业有限责任公司 一种稳定的奥美沙坦酯固体制剂
WO2013147462A1 (en) * 2012-03-30 2013-10-03 Daewoong Pharmaceutical Co., Ltd. Pharmaceutical composition comprising olmesartan medoxomil and rosuvastatin or its salt
CN105663070A (zh) * 2014-11-21 2016-06-15 深圳信立泰药业股份有限公司 一种含有奥美沙坦酯的药物组合物及其制备方法
CN105640913B (zh) * 2016-01-22 2018-11-02 山东省医学科学院药物研究所 一种奥美沙坦酯片及其制备方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3096248A (en) * 1959-04-06 1963-07-02 Rexall Drug & Chemical Company Method of making an encapsulated tablet
JPH0282519A (ja) 1988-09-19 1990-03-23 Sanyo Electric Co Ltd 固相エピタキシャル成長方法
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
JPH0624959A (ja) * 1991-10-04 1994-02-01 Bayer Yakuhin Kk 胃内浮遊型薬物徐放性固形製剤
US5298261A (en) * 1992-04-20 1994-03-29 Oregon Freeze Dry, Inc. Rapidly distintegrating tablet
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof
ATE308343T1 (de) * 1998-07-15 2005-11-15 Asahi Kasei Chemicals Corp Trägerhilfstoff
JP3796562B2 (ja) * 1999-05-26 2006-07-12 ライオン株式会社 多層錠、多層錠の製造方法及び多層錠の剥離抑制方法
CN1296387C (zh) * 2000-07-05 2007-01-24 旭化成株式会社 纤维素粉末
JP2002167327A (ja) * 2000-09-22 2002-06-11 Takeda Chem Ind Ltd 固形製剤
US20040132731A1 (en) * 2002-06-26 2004-07-08 Fox David Nathan Abraham Novel combination
KR101194453B1 (ko) * 2003-01-31 2012-10-24 다이이찌 산쿄 가부시키가이샤 동맥 경화 및 고혈압증의 예방 및 치료를 위한 의약
JP2009513543A (ja) 2003-07-16 2009-04-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング クロルタリドンの組み合わせ
JP4726628B2 (ja) * 2003-10-15 2011-07-20 富士化学工業株式会社 口腔内速崩壊性錠剤
GB0325291D0 (en) * 2003-10-29 2003-12-03 Pfizer Ltd Novel combination
KR20100012105A (ko) 2003-10-31 2010-02-05 다케다 야쿠힌 고교 가부시키가이샤 인슐린 감작제, 인슐린 분비촉진제 및 폴리옥시에틸렌 소르비탄 지방산 에스테르를 함유하는 고체 제제
WO2006029057A1 (en) 2004-09-02 2006-03-16 Teva Pharmaceutical Industries, Ltd. Purification of olmesartan medoxomil
CN101247832B (zh) * 2005-06-27 2011-12-28 第一三共株式会社 含有血管紧张素ⅱ受体拮抗剂和钙通道阻断剂的药物制剂
JP5063370B2 (ja) * 2005-06-27 2012-10-31 第一三共株式会社 湿式造粒製薬の調製方法
TWI388345B (zh) * 2005-06-27 2013-03-11 Sankyo Co 用於高血壓之預防或治療之包含血管緊張素ⅱ受體拮抗劑及鈣通道阻斷劑之固體劑型
EP1891952B1 (en) 2006-05-04 2011-10-05 LEK Pharmaceuticals d.d. Pharmaceutical composition of olmesartan medoxomil

Similar Documents

Publication Publication Date Title
JP2014024874A5 (enExample)
TR201909173T4 (tr) İşlevselleştirilmiş kalsiyum karbonat içeren hızlı parçalanan katı dozaj formundaki formülasyon ve bunun üretim yöntemi.
CL2013001586A1 (es) Composicion microgranular de rapida dispersion que comprende al menos un alcohol de azucar, un sacarido, o una mezcla de estos, al menos un super disgregante y al menos un aditivo multifuncion; comprimido de desintegracion oral que comprende la composicion microgranular y al menos un principio activo; y metodos de fabricacion.
JP2014167026A5 (enExample)
JP2015511635A5 (enExample)
ATE533476T1 (de) Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür
IN2014DE03239A (enExample)
RU2016117186A (ru) Комбинированная композиция, содержащая тадалафил и амлодипин
JP2009542678A5 (enExample)
RU2011107285A (ru) Новый способ
JP2016108327A5 (enExample)
CN103127010A (zh) 一种稳定的坎地沙坦酯片剂组合物
HRP20141134T1 (hr) Kruta farmaceutska formulacija
JP2015129124A5 (enExample)
JP2017520619A5 (enExample)
JP2009091362A5 (enExample)
JP2015129175A5 (enExample)
CN103860508A (zh) 一种盐酸二甲双胍缓释片及其制备方法
CN102349876A (zh) 一种治疗胃溃疡和十二指肠溃疡的药物及其配制方法
JP2016535762A5 (enExample)
CN101461815B (zh) 三氟柳药物组合物及其制备方法
Odeku Formulation of metronidazole tablets containing hydroxypropylated white yam (Dioscorea rotundata) starch as binding agent
CN103860507B (zh) 一种甲磺酸二氢麦角碱缓释片及其制备方法
JP4630614B2 (ja) 速崩壊性固形製剤
Saritha et al. Formulation of pioglitazone floating tablets: a comparative evaluation of olibanum, starch acetate and HPMC K15M